5PSQ-054 Drugs that extend the qt interval of the ecg: evaluation of oncological patients

BACKGROUND: Detection of drugs that produce prolongation of the QT interval is very important. PURPOSE: Oncological patients have an associated risk for QT prolongation due to hydroelectrolyte disturbances associated with their pathologies and the treatment received for side-effects related to antin...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Pin, M Lombardero, Egido, E Mateos, Medina, A Alamo, López, ME Luján, Morín, LSantos
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 5: Patient safety and quality assurance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535824/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.408
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars